Endocrine Abstracts

Thyroid diseases are common with thyroid dysfunction affecting up to 10% of the population and thyroid nodules occurring in more than 50% of people. I currently lead an internationally unique and wide-ranging programme of translational thyroid research, which integrates clinical and laboratory research with rigorously conducted clinical trials. My research findings are incorporated in national and international clinical management guidelines and drive professional training in addition to clinical and patient decisions in the UK and beyond. I am responsible for national policy setting related to the optimal management of thyroid diseases in the UK through leadership of UK thyroid guidelines (NICE, RCOG, BTA, BAETS) ensuring clinical and cost-effective healthcare delivery. Close collaboration with national patient groups ensures direct involvement of patients in decision-making processes and in driving the national research agenda relating to thyroid diseases. I believe that dissemination of research and generation of impact to the lay community are crucial elements of improving patient care. I actively engage with a number of national patient support groups including the British Thyroid Foundation (BTF) and the Butterfly Thyroid Cancer Trust (BTCT), and I am a regular speaker at their meetings. In response the COVID-19 pandemic, I have written guidance on the management of thyroid dysfunction during COVID-19. I am co-chair for the Society for Endocrinology project on the Future of Endocrine Services following the pandemic. This aims to facilitate the seizing of new opportunities ensuring world-class care for patients with endocrine disorders in the UK by harnessing research, education, and new ways of working. I feel privileged to receive this award and I am delighted to share this with my friend and colleague, Helen Simpson, who has transformed the care of patients with adrenal disorders.